Kathryn E. Falberg, Director at Axovant Sciences Ltd. (AXON), bought 107,874 shares at $18.54 ($2.0M) on 2017-04-17, disclosed to the SEC on 2017-04-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.54 | 53,937 | $1000K | 50.0% |
| 2 | $18.54 | 53,937 | $1000K | 50.0% |
| Total | $18.54 avg | 107,874 | $2.0M | 100% |
| Filing → |
| TTD | SELL | 2024-03-12 | $16.9M | — | Filing → |
| NUVB | BUY | 2022-12-05 | $789K | — | Filing → |
| TTD | SELL | 2021-11-23 | $32.5M | — | Filing → |